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Results: Typical changes in the antegrade recovery curve produced by R
are shown in the figure. There was a concentration dependent decrease in
ll.AH from the pre-drug value of 56 ± 15 ms to 29.2 ± 16.9 ms and 13.7 ± 5.9
ms by 3 and 6 x 10-6 M respectively (n = 6). A reciprocal increase in the AV
node effective refractory period was observed from 91 ± 15 ms (pre-drug)
to 139 ± 16 ms (3 x 10-6 M) and 170 ± 16 ms (6 x 10-6 M). AHx was
unchanged at any concentration of R.
Conclusions: These results suggest that class III antiarrhythmic agents
may increase action potential duration and the refractory period of the struc-
ture(s) limiting AV conduction and thereby eliminate a majority of the "slow"
AV node conduction. These findings may have important implications for a
pharmacologic approach to the treatment of AV node reentry tachycardias.
1947-1121 Has the Inotropic Effect of the Class-III
Antiarrhythmic Drug Amiodarone a Frequence-
dependency In Vivo?
pig and canine ventricular myocytes: slow (lKs) and rapid (lKr) delayed rec-
tifier. inward rectifier (lKII and transient outward (Ito) currents. To facilitate
the quantification and comparison of drug potencies, the recording condi-
tions were designed to "isolate" these K currents from other ionic currents
and from each other. In particular. since it is difficult to separate IKr and IKs
under normal physiological conditions. a Na- and Ca-free external solution
was used to dissect the two. This was confirmed by the selective action of
dofetilide. Azim blocked IKs concentration dependently (0.2-10 JLM) and re-
versibly. Block was potentiated by more positive Vt. At +30 mV, 2 JLM Azim
blocked IKs by 58 ± 13% (n = 6). Azim caused a time-dependent reduction of
IKs during depolarization and slowed IKs deactivation. suggesting that block
and unblock occurred mainly in the open state. Azim also blocked IKr con-
centration dependently (0.1-2 JLM) and reversibly. At -20 mV, 1 JLM Azim
blocked IKr by 86 ± 10% (n = 3). On the other hand, Ito (IC50 > 10 JLM. n
= 6) and IKI (IC50 > 50 JLM. n = 2) were much less sensitive to Azim than
IKr or IKs ' In conclusion. blockade of both delayed rectifiers makes important
contributions to the class III action of Azim.
Means ± SEM in % of preinfusion values, .p < 0.01
Martin E. Beyer, Hans Martin Hoffmeister, Ludger Seipel. Medical Hospital, Dept. III.
University of Tubingen, Germany
CL 300 600 900 1200
O-SOT 10-6 M +2 ± 3 +5 ± 3 +4±2 +4 ±3
0-5OT 10-5 M +11 ± 2' +14 ± 3' +10 ± 3' +11 ± 3'
O-SOT 5 x 10-5 M +18 ± 2' +22 ± 3' +24 ± 3' +45 ± 10'
OUIN 10-6 M +14 ± 5' +22 ± 6' +18 ± 4' +28 ± 4'
OUIN 10-5 M +22 ± 5' +15 ± 5' +29 ± 5" +31 ±6'
AMIO +3 ± 2 -4 ±2 -3 ± 2 +3 ± 3
Markus Zabel, Bettina S. Koller. Raymond L. Woosley, Michael R. Franz. Divisions
of Clinical Pharmacology and Cardiology, Georgetown University, & VA Medical Center,
Washington. DC
It has been hypothesized that antiarrhythmic as well as proarrhythmic effects
of antiarrhythmic drugs (AA) can be linked to changes in dispersion of ventric-
ular repolarization (OISP). The influence of d-sotalol (O-SOT). quinidine (OUIN)
and amiodarone (AMID) was studied in isolated Langendorff-perfused rabbit
hearts. Between 5--7 monophasic action potentials were recorded simulta-
neously from both ventricles at steady-state cycle lengths (CL) between 300
and 1200 msec and measured at 90% repolarization (AP090 ). OISP was de-
fined as APOgOmax - APDgOmin. The protocol was repeated after infusion
ofO-SOT(n = 12.10-6 M, 10-5 M and5 x 10-5 M)and OUIN(n = 8.10-6
M and 10-5 M). AMIO was given chronically po. for 4 weeks (n = 9) and
compared to n = 18 normal hearts. OISP change compared to the respec-
tive baseline (values ranged between 20-27 msec) is shown in the table at
selected CLs (all values mean ± SEM in msec, * p < 0.05). AMIO tissue
levels correlated with APO duration but not with OISP.
Comparative Effects of D-Sotalol, Quinidine and
Amiodarone on Dispersion of Ventricular
Repolarizatlon in the Isolated Intact Rabbit Heart
Aprotlnln Produces Ion Channels in lipid
Bilayers
spontaneous heart rate vagal stimulation
10 mglkg 20 mglkg NaCI 20 mg/kg NaCI
isovol. LVSP 93 ± 2 88± " 98± 1 80 ± 5' 100 ± 2
isovol. dp/dtmax 81 ± 3' 73 ± 3' 94± 3 54 ± 5' 82 ±4
cardiac output 90 ± 7 75 ± 7 93 ± 8 57 ± 6 68 ± 4
Conclusion: The prolongation of the action potential duration by the class-
III antiarrhythmic drug amiodarone does not cause in vivo a positive in-
otropic effect since the cardiodepressive effects of the drug (e.g. sodium-
and calcium-channel blockade) are stronger. A reverse use-dependence of
the inotropism of this drug is not detectable in vivo.
The prolongation of the action potential duration (APOI by class-III antiar-
rhythmic drugs causes in vitro a positive inotropic effect. On the other side a
frequence-dependency of the APD-prolongation ("reverse use-dependence")
was described. This would mean, that a heart rate reduction should have
a positive effect on myocardial contractility after administration of class-III
drugs.
We examined the hemodynamic effects of amiodarone (10 mg/kg, 20
mglkg Lv.) in thoracotomized rats vs. saline controls (NaCI) without and with
bradycardia. Heart rate reduction was produced by vagal stimulation (reduc-
tion about 50%). Besides measurements in the intact circulation isovolumic
maximum registrations (isovol. LVSP, isovol. dp/dtmax ) were performed to
determine myocardial contractility.
Conclusions: Neither of the three drugs with class III-action shows a re-
duction of OISP. While OUIN and O-SOT show dose-dependent increases in
OISP, especially at long CLs, AMIO tissue concentrations are not related to
OISP and no increase is seen at long CLs. These effects on DIS P may ex-
plain the different clinical incidence of torsade de pointes between the three
drugs.
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Cardiac baroreflex (CBR) control of forearm blood flow (FBF) is blunted or
reversed in humans with heart failure (HF). but little is known about CBR
control of renal cortical blood flow (RCBF) in HF due to technical limitations.
Positron emission tomography (PETI 0-15 water is a new, precise method to
measure RCBF quantitatively. We compared CBR control of RCBF and FBF
(venous plethysmography) in 8 patients with HF (mean age. 47 ± 3 y. ejection
fraction 0.25 ± 0.02) and 10 normal humans (mean age 35 ± 5 y) during CBR
unloading with phlebotomy (450 ml). In 5 normals. cold pressor test was
Preserved Cardiac Baroreflex Control of Renal
Cortical Blood Flow in Advanced Heart Failure
Patients: A Positron Emission Tomography Study
1948-461
Steven Hanish. Siava Titov, Richard Kovacs. Department ofMedical Research,
Methodist Hospital. Indianapolis, IN
Aprotinin. a 58 Amino Acid peptide protease inhibitor. is used clinically to pre-
vent postoperative blood loss and reduce transfusion requirements in those
procedures which employ extracorporeal circulation. Its mechanism of ac-
tion is unknown. We have observed that Aprotinin has produced channel-like
artifacts in other experimental systems. We tested the hypothesis that Apro-
tinin could form ion channels in lipid bilayers. Lipid bilayers were created
on the tips of patch clamp pipets using phosphatidylethanolamine, phos-
phatidylserine and cholesterol in a 5:3:2 ratio respectively. Single channel
currents were recorded in symmetric solutions of KCI + Tris/HEPES. pH =
7.2. as well as asymmetric solutions. Aprotinin was added to the bath solu-
tion. Data were digitized and recorded on video tape for off-line analysis using
custom software. 8 JLM Aprotinin produced typical ion channel currents in
symmetric solutions of KCI at concentrations of 50 mM. 100 mM. 150 mM,
and 250 mM, with resultant peak currents of 7.33 pA. The conductance of
the Aprotinin channel was 31.8 pS in 250 mM KCI. Aprotinin exhibited mul-
tiple conductance levels and complex kinetics. In 250 mM potassium, the
channel had a steady state Popen of 0.5. Popen was not voltage dependent.
The channels were saturable, selective. and highly specific for potassium
ions over sodium ions. No definite blockers of the channel have yet been
identified. Our experiments show that Aprotinin produces ion channels in
lipid bilayers, and this in turn may lead to better understanding this drug's
mechanism of action.
Effects of Azimilide (NE-10064) on Cardiac K
Channels
J.-A. Yao. G.-N. Tseng. Columbia University, New York. NY
To understand the cellular mechanism of action of azimilide (Aziml. a novel
class III antiarrhythmic agent, we studied its effegts on K currents in guinea
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Prognostic Importance of the Oxidation Products
of Catecholamines (Adrenochromes) in Patients
with Heart Failure
Bertram Pitt. Jean L. Rouleau, John Nicklas, Milton Packer, Gordon Moe,
Christian Hall, Jacques de Champlain, Naranjan S. Dhalla, PROFILE Investigators.
Ann Arbor, MI
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In a multivariant model inclUding these variables, as well as NYHA class,
gender, and treatment groups (flosequinan or placebo), AL was the most
significant predictor of death (P = 0.005). In patients dying with progressive
HF or of other causes, AL was a better predictor of death than NE, while in
patients dying of a sudden cardiac death, NE was a better predictor. Thus,
measurement of AL appears to be a new prognostic factor in patients with
HF. These results suggest a role for free-radical formation in the pathophys-
iologyof HF and provide a new opportunity for therapy.
In experimental models of heart failure (HF) free-radical formation has
been shown to be increased and considered to be involved in patho-
physiologic mechanisms leading to progressive ventricular dysfunction.
Adrenochromes, the products of oxidation of norepinephrine (NE) are
thought to reflect oxidative stress (amount of free-radical formation) and to
be more cytotoxic than NE. To investigate the importance of adrenochromes
in HF, we measured adrenolutins (AL), stable breakdown products of
adrenochromes, along with plasma NE, and N-terminal atrial natriuretic fac-
tor {ANFI in 257 patients at baseline entering the PROFILE study of flose-
quinan. We then related these variables to mortality (21 - progressive HF.
27 - sudden cardiac deaths and 9 - other causes) over a 20-month period.
Pre HM W2 W4 W8
PV 117 ± 22 123 ± 17 119 ± 19 111 ± 12
ANF 276 ± 199 199 ± 62 180± 110 141 ± 66
PA 53 ± 52 16 ± g 17 ± 18 14 ± 9*
PRA 46 ± 25 7 ± 3* 8 ± 7* 11 ± 18*
AVP 5.2 ± 5 O.8± 1 0.6 ± 07* 1.1 ± 1*
Congestive heart failure is associated with blood volume expansion which by
itself increases the burden on the heart. High PV with congestive heart failure
has been attributed to stimulation of the renin-aldersterone system and AVP.
The use of left ventricular assist devices as bridges to heart transplantation
has increased the survival of these patients during this critical period. We hy-
pothesized that improvement of cardiac mechanical function by HeartMate
(left ventricular assist device) is associated with a normalization of volume
load secondary to normalization of neurohumoral determinants of plasma
volume. To assess this hypothesis, we studied 15 patients (13 M: 2 F; age 50
± 9 yrs) with end stage heart failure who were cardiac transplant candidates,
before and after HeartMate 1000 (HM) implantation. We measured plasma
volume (pV, RISA). and plasma levels of atrial natiuretic hormone (ANFI. al-
dosterone (PA), renin (PRA), and arginine vasopressin (AVP). sequentially at
pre HM, and post HM (weeks 2, 4 and 8). Results:
Plasma aldosterone levels were significantly lower during high-dose than
during low-dose lisinopril treatment at both 6 hours (p < 0.03) and at 22 hours
(p < 0.04).
Conclusion: The suppression of aldosterone activity during chronic ACE
inhibitor therapy in patients with heart failure is dose-dependent. This pro-
vides further evidence that ACE inhibitors should be routinely prescribed in
high doses.
x± SO, P(paired t): * < 005 vs pre HM
Conclusions: The reduction of PV, PRA, PA and AVP occurs earlier than
the reduction of plasma volume and ANF after HeartMate, possibly due to
decreased pulmonary congestion and improved renal perfusion. The reduc-
tion of ANF cannot be responsible for lack of adequate decrease of plasma
volume; its reduction can be taken as a marker of improved cardiac pump
function and decreased atrial stretch.
Dissociation Between Changes of Plasma Volume
and Its Neurohumoral Determinants
Post-HeartMate Implantation in Heart Failure
Patients
Safwan Jaalouk, Patrick M. McCarthy, Emmanuel L. Bravo, Fetnat M. Fouad-Tarazi.
The Cleveland Clinic Foundation, Cleveland, OH
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Mean Plasma Aldosterone Concentration(pg/ml)
Peak (6 hours) Trough (22 hours)
163.0 186.7
98.4 118.4
High-dose Llsinopril is More Effective than
Low-dose in Suppressing Aldosterone in Patients
with Chronic Heart Failure
PCWP BNP ANP cGMP
---C HF C HF C HF C HF
BNP-O 9 31 t 12 571 84 7451 14 16
BNP-25 8 29 273* 521* 99 910* 28* 19
BNP-50 6* 28* 611* 1053* 93 884* 31* 24*
BNP-l00 6* 26* 769* 1230* 104* 871* 32* 24*
pSD 2 4 250 284 33 149 4 6
Natriuretic Peptides and cGMP: Insights into
Their Functional Role in Heart Failure
Gordon W. Moe, Etienne A. Grima, Norman L.M. Wong, Robert J. Howard. U of
Toronto, Toronto, Ontado
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used as a strong, non-baroreflex mediated stimulus to vasoconstriction.
Results: Phlebotomy decreased central venous pressure (p < 0.001), but
did not change mean arterial pressure or heart rate in HF patients or con-
trols. The major findings of the study are: 1) At rest, RCBF is markedly di-
minished in HF vs normals (2.4 ± 0.1 vs 4.3 ± 0.2 mllmin/g, p < 0.001). 2)
In normal humans during phlebotomy, FBF decreased substantially (basal vs
phlebotomy: 3.3 ± 0.4 vs 2.6 ± 0.3 mllmin/100 ml, p = 0.021, and RCBF de-
creased slightly, but significantly (basal vs phlebotomy:4.3 ± 0.2 vs 4.0 ± 0.3
mllminlg, p = 0.01). 3) The small magnitude of reflex renal vasoconstriction
is not explained by the inability of the renal circulation to vasoconstrict since
the cold pressor stimulus induced substantial decreases in RCBF in normals
(basal vs cold pressor: 4.4 ± 0.1 vs 3.7 ± 0.1 mllminlg, p = 0.003). 4) In
humans with heart failure during phlebotomy, FBF did not change (basal vs
phlebotomy:2.6 ± 0.3 vs 2.7 ± 0.2 ml/min/100 ml, p = NS), but RCBF de-
creased slightly but significantly (basal vs phlebotomy:2.4 ± 0.1 vs 2.1 ± 0.1
mllmin/g, p = 0.01). Thus, in patients with heart failure, there is an abnor-
mality in cardiopulmonary baroreflex control of the forearm circulation, but
not the renal circulation.
Conclusion: This study 1) shows the power of PET to study physiologic
and pathophysiologic reflex control of the renal circulation in humans, and
2) describes the novel finding of selective dysfunction of cardiac baroreflex
control of the forearm circulation, but its preservation of the renal circulation,
in patients with heart failure.
Neil C. Davidson, Wendy J. Coutie, Allan D. Struthers. University of Dundee,
Dundee, Scotland, UK
The optimal dose of ACE inhibitor for the treatment of heart failure is highly
controversial and it is uncertain whether the neurohormonal suppression pro-
duced by these drugs is dose-dependent. We therefore compared the effects
of low-dose and high-dose lisinopril therapy on plasma levels of aldosterone,
which causes several important adverse effects including hypokalaemia, hy-
pomagnesaemia and stimulation of myocardial fibrosis. 15 patients with
LVEF < 45%, on chronic ACE inhibitor therapy, were given lisinopril 5 mg
o.d. and 20 mg o.d. for two weeks each in a randomised order. At the end
of each treatment period plasma aldosterone levels were measured, after
30 minutes bed rest, at 6 hours (peak effect) and 22 hours (trough effect)
after the dose of lisinopril. The levels of aldosterone on each dose at these
timepoints were compared using ANOVA.
Plasma atrial and brain natriuretic peptide levels (ANP and BNP) are elevated
in heart failure (HF) but their functional significance is unclear. Accordingly,
we measured plasma ANP. BNP Ipg/ml). and their second messenger cGMP
(pmol/ml) together with PCWP (mmHg) in 8 dogs, before (BNP-O) and during
infusion of synthetic BNP (25,50 and 100 nglkg/min; BNP-25, BNP-50 and
BNP-1 00). at control (C) and HF after 3 wks of pacing. Mean data and pooled
SD (pSDI from analysis of variance are shown.
*p < 0.05 vs BNP-O. 1P < 0.05 vs C
At HF, the elevated endogenous BNP and ANP (BNP-OI were unable to
increase cGMP. Exogenous BNP induced a marked rise in plasma BNP. and
also increased plasma ANP and cGMP at both C and HF. The observation that
a higher plasma BNP level than that produced endogenously in HF is needed
to elevate cGMP suggest that the increased circulating BNP may not playa
functional role, although an important paracrine role cannot be ruled out.
Furthermore, the fact that exogenous BNP increases plasma ANP despite
falling PCWP suggests that BNP may compete with ANP for the clearance
(NPR-C) receptors.
Lisinopril Dose
5 mg o.d.
20 mg o.d.
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